Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
Go to our pre-filtered search.
Human Monoclonal C3B Primary Antibody for IHC (fro), WB - ABIN2477797
Hallström, Nordström, Tan, Manolov, Lambris, Isenman, Zipfel, Blom, Riesbeck: Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding. in Journal of immunology (Baltimore, Md. : 1950) 2011
There is direct interaction between C3(H2O) and CD11b (show ITGAM Antibodies). Contact-activated C3(H2O) is a novel ligand for CD11b/CD18 (show ITGAM Antibodies) that mediates platelet-PMN (show TBCE Antibodies) complex formation and the binding of platelet-derived microparticles to PMNs.
Low sC3 (show SCAMP3 Antibodies) levels and histologic signs of thrombotic microangiopathy are associated with a poor renal prognosis in patients with ANCA-associated renal vasculitis.
The aim of this study was to perform a meta-analysis on rs2230199 C>G single nucleotide polymorphism (SNP) in complement component 3P in relation to AMD (show AMD1 Antibodies)
Patients with advanced atrophic AMD (show AMD1 Antibodies) carried these rare variants more frequently than patients with neovascular AMD (show AMD1 Antibodies) (11 of 93 [11.8%] vs 40 of 835 [4.8%]; P = .04).
Our results identified TWIST1 (show TWIST1 Antibodies) as a transcription factor that regulates C3 expression during pathologic and physiologic epithelial-mesenchymal transition
sublingual immunotherapy for Japanese cedar pollinosis affects levels of IL-17A (show IL17A Antibodies) and complement components 3a and 5a
Complement component C3 and butyrylcholinesterase (show BCHE Antibodies) activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
C4BP (show C4BPA Antibodies) is deposited in the diseased aortic valve, coincident with C3d (show C3 Antibodies) expression.
Plasmin (show PLG Antibodies) cleavage of iC3b provides a complement regulatory pathway that is as efficient as FI/CR1 (show CR1 Antibodies) but does not require a cellular cofactor.
we found two of the three binding sites to be similarly stable while varying in the number of contacts to C3d (show C3 Antibodies) . These sites are likely physiologically relevant and may facilitate multivalent binding of FH CCP (show CRYGD Antibodies) 19-20 to C3b and either C3d (show C3 Antibodies)
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection.
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1
, C3a anaphylatoxin
, acylation-stimulating protein cleavage product
, complement C3
, complement component C3
, complement component C3a
, complement component C3b